Deciphering the transcriptomic landscape of tumor-infiltrating CD8 lymphocytes in B16 melanoma tumors with single-cell RNA-Seq

References

• Mclane LM, Abdel-Hakeem MS, Wherry EJ. CD8 T Cell exhaustion during chronic viral infection and cancer. 2019. doi: 10.1146/annurev-immunol-041015.
   Google Scholar
• Speiser DE, Utzschneider DT, Oberle SG, Münz C, Romero P, Zehn D. T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion? Nat Rev Immunol. 2014;14(11):768–15. doi: 10.1038/nri3740.
   PubMed Web of Science ®Google Scholar
• Li H, van der Leun AM, Yofe I, Lubling Y, Gelbard-Solodkin D, van Akkooi ACJ, van den Braber M, Rozeman EA, Haanen JBAG, Blank CU. et al. Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma. Cell. 2019; 176(4):775–789.e18. doi: 10.1016/j.cell.2018.11.043.
   PubMed Web of Science ®Google Scholar
• Philip M, Schietinger A. Heterogeneity and fate choice: T cell exhaustion in cancer and chronic infections. Curr Opin Immunol. Elsevier Current Trends. 2019;58:98–103. doi: 10.1016/J.COI.2019.04.014.
   PubMed Web of Science ®Google Scholar
• Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJM, Robert L, Chmielowski B, Spasic M, Henry G, Ciobanu V. et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature. 2014;515:568–571. doi: 10.1038/nature13954
   PubMed Web of Science ®Google Scholar
• Miller BC, Sen DR, Al Abosy R, Bi K, Virkud YV, LaFleur MW, Yates KB, Lako A, Felt K, Naik GS. et al. Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade. Nat Immunol. Nature Publishing Group. 2019; 20(3):326–336. doi: 10.1038/s41590-019-0312-6.
   PubMed Web of Science ®Google Scholar
• Siddiqui I, Schaeuble K, Chennupati V, Fuertes Marraco SA, Calderon-Copete S, Pais Ferreira D, Carmona SJ, Scarpellino L, Gfeller D, Pradervand S. et al. Intratumoral Tcf1+PD-1+CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity. Cell Press. 2019;50 (1):195–211.e10. doi: 10.1016/J.IMMUNI.2018.12.021.
   PubMed Web of Science ®Google Scholar
• He R, Hou S, Liu C, Zhang A, Bai Q, Han M, Yang Y, Wei G, Shen T, Yang X. et al. Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection. Nat. 2016;537(7620):412–416. doi: 10.1038/nature19317.
   Google Scholar
• Im SJ, Hashimoto M, Gerner MY, Lee J, Kissick HT, Burger MC, Shan Q, Hale JS, Lee J, Nasti TH, et al. Defining CD8 + T cells that provide the proliferative burst after PD-1 therapy. Nat. 2016;537(7620):417–421. doi: 10.1038/nature19330.
   Google Scholar
• Kallies A, Zehn D, Utzschneider DT Precursor exhausted T cells: key to successful immunotherapy ? Nat Rev Immunol. Nature Publishing Group. 2019:1–9. doi: 10.1038/s41577-019-0223-7.
   PubMed Web of Science ®Google Scholar
• Utzschneider DT, Charmoy M, Chennupati V, Pousse L, Ferreira DP, Calderon-Copete S, Danilo M, Alfei F, Hofmann M, Wieland D, et al. T cell factor 1-expressing memory-like CD8+ T cells sustain the immune response to chronic viral infections. Immunity. 2016;45(2):415–427. doi: 10.1016/j.immuni.2016.07.021.
   PubMed Web of Science ®Google Scholar
• Wu T, Ji Y, Moseman EA, Xu HC, Manglani M, Kirby M, Anderson SM, Handon R, Kenyon E, Elkahloun A. et al. The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness. Sci Immunol. 2016;1 (6):eaai8593–eaai8593. doi: 10.1126/sciimmunol.aai8593.
   PubMed Web of Science ®Google Scholar
• Overwijk WW, Theoret MR, Finkelstein SE, Surman DR, de Jong LA, Vyth-Dreese FA, Dellemijn TA, Antony PA, Spiess PJ, Palmer DC. et al. Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8 + T cells. J Exp Med. 2003;198(4):569–580. doi: 10.1084/jem.20030590.
   PubMed Web of Science ®Google Scholar
• Rempala GA, Seweryn M. Methods for diversity and overlap analysis in T-cell receptor populations. J Math Biol. 2013;67(6–7):1339–1368. doi: 10.1007/s00285-012-0589-7.
   PubMed Web of Science ®Google Scholar
• Scrucca L, Fop M, Murphy T, Raftery A. mclust 5: clustering, classification and density estimation using gaussian finite mixture models.. R J. 2016;8:289. doi: 10.32614/RJ-2016-021
   PubMedGoogle Scholar
• Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM, Hao Y, Stoeckius M, Smibert P, Satija R. et al. Comprehensive integration of single-cell data. Cell. Cell Press. 2019;177:1888–1902.e21. doi: 10.1016/J.CELL.2019.05.031.
   PubMed Web of Science ®Google Scholar
• Finak G, McDavid A, Yajima M, Deng J, Gersuk V, Shalek AK, Slichter CK, Miller HW, McElrath MJ, Prlic M. et al. MAST: A flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 2015;16. doi: 10.1186/s13059-015-0844-5.
   PubMed Web of Science ®Google Scholar
• Aibar S, González-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, Rambow F, Marine JC, Geurts P, Aerts J, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. Nature Publishing Group. 2017;14(11):1083–1086. doi: 10.1038/nmeth.4463.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Kalia V, Haining WN, Konieczny BT, Subramaniam S, Ahmed R. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J Exp Med. 2008;205(3):625–640. doi: 10.1084/jem.20071641.
   PubMed Web of Science ®Google Scholar
• Schietinger A, Philip M, Krisnawan VE, Chiu EY, Delrow JJ, Basom RS, Lauer P, Brockstedt DG, Knoblaugh SE, Hämmerling GJ. et al. Tumor-specific T cell dysfunction is a dynamic antigen-driven differentiation program initiated early during tumorigenesis. Immunity. Cell Press. 2016;45(2):389–401. doi: 10.1016/J.IMMUNI.2016.07.011.
   PubMed Web of Science ®Google Scholar
• Tirosh I, Izar B, Prakadan SM, Wadsworth MH, Treacy D, Trombetta JJ, Rotem A, Rodman C, Lian C, Murphy G. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352(6282):189–196. doi: 10.1126/science.aad0501.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang L-G, Han Y, He Q-Y. Clusterprofiler: an R package for comparing biological themes among gene clusters. OMICS J Integr Biol. Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA. 2012;16 (5):284–287. doi: 10.1089/omi.2011.0118.
   PubMed Web of Science ®Google Scholar
• Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114–2120. doi: 10.1093/bioinformatics/btu170.
   PubMed Web of Science ®Google Scholar
• Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14(4):417–419. doi: 10.1038/nmeth.4197.
   PubMed Web of Science ®Google Scholar
• Soneson C, Love MI, Robinson MD. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences.. F1000Res. Faculty of 1000 Ltd. 2015;4:1521. doi: 10.12688/f1000research.7563.2.
   PubMedGoogle Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. BioMed Central. 2014;15(12):550. doi: 10.1186/s13059-014-0550-8.
   PubMed Web of Science ®Google Scholar
• Gubin MM, Zhang X, Schuster H, Caron E, Ward JP, Noguchi T, Ivanova Y, Hundal J, Arthur CD, Krebber W-J. et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nat. NIH Public Access. 2014;515(7528):577–581. doi: 10.1038/nature13988.
   Google Scholar
• Markowitz GJ, Havel LS, Crowley MJ, Ban Y, Lee SB, Thalappillil JS, Narula N, Bhinder B, Elemento O, Wong ST, et al. Immune reprogramming via PD-1 inhibition enhances early-stage lung cancer survival. JCI Insight. American Society for Clinical Investigation. 2018;3(13). doi: 10.1172/jci.insight.96836.
   Web of Science ®Google Scholar
• Mognol GP, Spreafico R, Wong V, Scott-Browne JP, Togher S, Hoffmann A, Hogan PG, Rao A, Trifari S. Exhaustion-associated regulatory regions in CD8+ tumor-infiltrating T cells. Proc Natl Acad Sci U S A. National Academy of Sciences 2017;114(13):E2776–E2785. doi: 10.1073/pnas.1620498114.
   PubMed Web of Science ®Google Scholar
• Scott AC, Dündar F, Zumbo P, Chandran SS, Klebanoff CA, Shakiba M, Trivedi P, Menocal L, Appleby H, Camara S. et al. TOX is a critical regulator of tumour-specific T cell differentiation. Nat. 2019;571:270–274. doi: 10.1038/s41586-019-1324-y
   Google Scholar
• Singer M, Wang C, Cong L, Marjanovic ND, Kowalczyk MS, Zhang H, Nyman J, Sakuishi K, Kurtulus S, Gennert D, et al. A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T cells HHS public access graphical abstract. Cell. 2016;166 (6):1500–1511. doi: 10.1016/j.cell.2016.08.052.
   PubMed Web of Science ®Google Scholar
• Barron M, Li J. Identifying and removing the cell-cycle effect from single-cell RNA-sequencing data. Sci Rep. 2016;6. doi: 10.1038/srep33892
   Web of Science ®Google Scholar
• McDavid A, Dennis L, Danaher P, Finak G, Krouse M, Wang A, Webster P, Beechem J, Gottardo R. Modeling Bi-modality improves characterization of cell cycle on gene expression in single cells. PLoS Comput Biol. 2014;10:e1003696. doi: 10.1371/journal.pcbi.1003696.
   PubMed Web of Science ®Google Scholar
• Scialdone A, Natarajan KN, Saraiva LR, Proserpio V, Teichmann SA, Stegle O, Marioni JC, Buettner F. Computational assignment of cell-cycle stage from single-cell transcriptome data. Methods. 2015;85:54–61. doi: 10.1016/j.ymeth.2015.06.021
   PubMed Web of Science ®Google Scholar
• Zerbino DR, Achuthan P, Akanni W, Amode M, Barrell D, Bhai J, Billis K, Cummins C, Gall A, Girón CG. et al. Ensembl 2018. Nucleic Acids Res. Narnia. 2018;46(D1):D754–D761. doi: 10.1093/nar/gkx1098.
   PubMed Web of Science ®Google Scholar
• Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent.. J Stat Softw. 2010;33 doi: 10.18637/jss.v033.i01
   PubMed Web of Science ®Google Scholar
• Xiong H, Mittman S, Rodriguez R, Pacheco-Sanchez P, Moskalenko M, Yang Y, Elstrott J, Ritter AT, Müller S, Nickles D. et al. Coexpression of inhibitory receptors enriches for activated and functional CD8+ T cells in murine syngeneic tumor models. Cancer Immunol Res. 2019;7(6):963–976. doi: 10.1158/2326-6066.CIR-18-0750.
   PubMed Web of Science ®Google Scholar
• Kurtulus S, Madi A, Escobar G, Klapholz M, Nyman J, Christian E, Pawlak M, Dionne D, Xia J, Rozenblatt-Rosen O et al. Checkpoint blockade immunotherapy induces dynamic changes in PD-1-CD8 + tumor-infiltrating T cells. Immunity. 2019;50:181–194.e6. doi: 10.1016/j.immuni.2018.11.014.
   PubMed Web of Science ®Google Scholar
• Gubin MM, Esaulova E, Ward JP, Malkova ON, Runci D, Wong P, Noguchi T, Arthur CD, Meng W, Alspach E. et al. High-dimensional analysis delineates myeloid and lymphoid compartment remodeling during successful immune-checkpoint cancer therapy. Cell. Cell Press. 2018;175 (4):1014–1030.e19. doi: 10.1016/J.CELL.2018.09.030.
   PubMed Web of Science ®Google Scholar
• Sade-Feldman M, Yizhak K, Bjorgaard SL, Ray JP, de Boer CG, Jenkins RW, Lieb DJ, Chen JH, Frederick DT, Barzily-Rokni M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell. 2018;175(4):998–1013.e20. doi: 10.1016/j.cell.2018.10.038.
   PubMed Web of Science ®Google Scholar
• Rue-Albrecht K, Marini F, Soneson C, Lun ATL. iSEE: interactive summarized experiment explorer. F1000Research. 2018;7:741. doi: 10.12688/f1000research.14966.1.
   PubMedGoogle Scholar
• Alfei F, Kanev K, Hofmann M, Wu M, Ghoneim HE, Roelli P, Utzschneider DT, von Hoesslin M, Cullen JG, Fan Y. et al. TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection. Nature. 2019;571:265–269. doi: 10.1038/s41586-019-1326-9
   PubMed Web of Science ®Google Scholar
• Khan O, Giles JR, McDonald S, Manne S, Ngiow SF, Patel KP, Werner MT, Huang AC, Alexander KA, Wu JE. et al. TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion Nature. 2019;571:211–218. doi: 10.1038/s41586-019-1325-x.
   PubMed Web of Science ®Google Scholar
• Yao C, Sun H-W, Lacey NE, Ji Y, Moseman EA, Shih H-Y, Heuston EF, Kirby M, Anderson S, Cheng J. et al. Single-cell RNA-seq reveals TOX as a key regulator of CD8+ T cell persistence in chronic infection. Nat Immunol. Nature Publishing Group. 2019;20(7):890–901. doi: 10.1038/s41590-019-0403-4.
   PubMed Web of Science ®Google Scholar
• Haas Q, Boligan KF, Jandus C, Schneider C, Simillion C, Stanczak MA, Haubitz M, Seyed Jafari SM, Zippelius A, Baerlocher GM et al. Siglec-9 regulates an effector memory CD8 + T-cell subset that congregates in the melanoma tumor microenvironment. Cancer Immunol Res. American Association for Cancer Research. 2019;7(5):707–718. doi: 10.1158/2326-6066.CIR-18-0505.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yu X, Zheng L, Zhang Y, Li Y, Fang Q, Gao R, Kang B, Zhang Q, Huang JY et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature. Nature Publishing Group. 2018;564(7735):268–272. doi: 10.1038/s41586-018-0694-x.
   PubMed Web of Science ®Google Scholar
• Utzschneider DT, Alfei F, Roelli P, Barras D, Chennupati V, Darbre S, Delorenzi M, Pinschewer DD, Zehn D. High antigen levels induce an exhausted phenotype in a chronic infection without impairing T cell expansion and survival. J Exp Med. The Rockefeller University Press. 2016;213(9):1819–1834. doi: 10.1084/jem.20150598.
   PubMed Web of Science ®Google Scholar
• Cerwenka A, Reome JB, Swain SL, Dutton RW, Carter LL. In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. J Immunol. 1998;161:97–105.
   PubMed Web of Science ®Google Scholar
• Pihlgren M, Dubois PM, Tomkowiak M, Sjögren T, Marvel J Resting memory CD8+ T cells are hyperreactive to antigenic challenge in vitro. J Exp Med. 1996;184:2141–2152. doi: 10.1084/jem.184.6.2141.
   PubMed Web of Science ®Google Scholar
• Walunas TL, Bruce DS, Dustin L, Loh DY, Bluestone JA. Ly-6C is a marker of memory CD8+ T cells. J Immunol (Baltimore, Md. : 1950). American Association of Immunologists. 1995;155(4):1873–1883. [accessed 2019 Aug 6]. http://www.ncbi.nlm.nih.gov/pubmed/7543536.
   PubMed Web of Science ®Google Scholar
• Groom JR, Luster AD CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol. NIH Public Access. 2011;89(2):207–215. doi: 10.1038/icb.2010.158.
   PubMed Web of Science ®Google Scholar
• Thompson ED, Enriquez HL, Fu Y-X, Engelhard VH. Tumor masses support naive T cell infiltration, activation, and differentiation into effectors. J Exp Med. 2010;207(8):1791–1804. doi: 10.1084/jem.20092454.
   PubMed Web of Science ®Google Scholar
• Weinberger J, Jimenez-Heredia R, Schaller S, Suessner S, Sunzenauer J, Reindl-Schwaighofer R, Weiss R, Winkler S, Gabriel C, Danzer M. et al. Immune repertoire profiling reveals that clonally expanded B and T cells infiltrating diseased human kidneys can also be tracked in blood. PLoS One. 2015;10:e0143125. doi: 10.1371/journal.pone.0143125.
   PubMed Web of Science ®Google Scholar
• Curran MA, Montalvo W, Yagita H, Allison JP. PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proc Natl Acad Sci U S A. National Academy of Sciences. 2010;107(9):4275–4280. doi: 10.1073/pnas.0915174107.
   PubMed Web of Science ®Google Scholar
• Gide TN, Quek C, Menzies AM, Tasker AT, Shang P, Holst J, Madore J, Lim SY, Velickovic R, Wongchenko M. et al. Distinct immune cell populations define response to anti-PD-1 monotherapy and anti-PD-1/anti-CTLA-4 combined therapy. Cancer Cell. Cell Press. 2019;35(2):238–255.e6. doi: 10.1016/J.CCELL.2019.01.003.
   PubMed Web of Science ®Google Scholar
• Wei SC, Levine JH, Cogdill AP, Zhao Y, Anang NAAS, Andrews MC, Sharma P, Wang J, Wargo JA, Pe’er D et al. Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade’, Cell. Cell Press. 2017;170 (6):1120–1133.e17. doi: 10.1016/J.CELL.2017.07.024.
   PubMed Web of Science ®Google Scholar
• Guo X, Zhang Y, Zheng L, Zheng C, Song J, Zhang Q, Kang B, Liu Z, Jin L, Xing R. et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat Med. 2018;24(7):978–985. doi: 10.1038/s41591-018-0045-3.
   PubMed Web of Science ®Google Scholar
• Jerby-Arnon L, Shah P, Cuoco MS, Rodman C, Su M-J, Melms JC, Leeson R, Kanodia A, Mei S, Lin J-R. et al. A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade. Cell. Cell Press. 2018;175(4):984–997.e24. doi: 10.1016/J.CELL.2018.09.006.
   PubMed Web of Science ®Google Scholar
• Kang B, Zheng C, Zheng L, Yoo JK, Guo H, Zhang Y, Guo X, Kang B, Hu R, Huang JY, et al. Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell. 2017;169(7):1342–1356.e16. doi: 10.1016/j.cell.2017.05.035.
   PubMed Web of Science ®Google Scholar
• Brummelman J, Mazza EMC, Alvisi G, Colombo FS, Grilli A, Mikulak J, Mavilio D, Alloisio M, Ferrari F, Lopci E. et al. High-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T cells infiltrating human tumors. J Exp Med. Rockefeller University Press. 2018;215(10):2520–2535. doi: 10.1084/jem.20180684.
   PubMed Web of Science ®Google Scholar
• Scheper W, Kelderman S, Fanchi LF, Linnemann C, Bendle G, de Rooij MAJ, Hirt C, Mezzadra R, Slagter M, Dijkstra K. et al. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat Med. 2019;25(1):89–94. doi: 10.1038/s41591-018-0266-5.
   PubMed Web of Science ®Google Scholar
• Simoni Y, Becht E, Fehlings M, Loh CY, Koo S-L, Teng KWW, Yeong JPS, Nahar R, Zhang T, Kared H. et al. Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates. Nat. Nature Publishing Group. 2018;557(7706):575–579. doi: 10.1038/s41586-018-0130-2.
   Web of Science ®Google Scholar
• Martínez-Usatorre A, Donda A, Zehn D, Romero P. PD-1 blockade unleashes effector potential of both high- and low-affinity tumor-infiltrating T cells. J Immunol. 2018;201:792–803. doi: 10.4049/jimmunol.1701644.
   PubMed Web of Science ®Google Scholar
• Blank CU, Haining WN, Held W, Hogan PG, Kallies A, Lugli E, Lynn RC, Philip M, Rao A, Restifo NP, et al. Defining “T cell exhaustion”. Nat Rev Immunol. Nature Publishing Group. 2019:1–10. doi: 10.1038/s41577-019-0221-9.
   PubMed Web of Science ®Google Scholar
• Lee PY, Wang J-X, Parisini E, Dascher CC, Nigrovic PA. Ly6 family proteins in neutrophil biology. J Leukoc Biol. John Wiley & Sons, Ltd. 2013;94(4):585–594. doi: 10.1189/jlb.0113014.
   PubMed Web of Science ®Google Scholar
• Piranlioglu R, Lee E, Ouzounova M, Bollag RJ, Vinyard AH, Arbab AS, Marasco D, Guzel M, Cowell JK, Thangaraju M et al. Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model. Nat Commun. Nature Publishing Group. 2019;10(1):1430. doi: 10.1038/s41467-019-09015-1.
   PubMedGoogle Scholar
• Chow MT, Ozga AJ, Servis RL, Frederick DT, Lo JA, Fisher DE, Freeman GJ, Boland GM, Luster AD. Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy. Immunity. Elsevier. 2019. doi: 10.1016/j.immuni.2019.04.010.
   PubMed Web of Science ®Google Scholar
• Corgnac S, Boutet M, Kfoury M, Naltet C, Mami-Chouaib F. The emerging role of CD8+ tissue resident memory T (TRM) cells in antitumor immunity: a unique functional contribution of the CD103 integrin. Front Immunol. Frontiers Media SA. 2018;9:1904. doi: 10.3389/fimmu.2018.01904.
   PubMed Web of Science ®Google Scholar
• Denucci CC, Mitchell JS, Shimizu Y Integrin function in T-cell homing to lymphoid and nonlymphoid sites: getting there and staying there. Crit Rev Immunol. NIH Public Access. 2009;29(2):87–109. [accessed 2019 Oct 8]. http://www.ncbi.nlm.nih.gov/pubmed/19496742.
   PubMed Web of Science ®Google Scholar
• Yost KE, Satpathy AT, Wells DK, Qi Y, Wang C, Kageyama R, McNamara KL, Granja JM, Sarin KY, Brown RA, et al. Clonal replacement of tumor-specific T cells following PD-1 blockade. Nat Med. Nature Publishing Group. 2019:1–9. doi: 10.1038/s41591-019-0522-3
   PubMed Web of Science ®Google Scholar